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CHAPTER I 
INTRODUCTION 
During the last thirty years, a variety of pharma­
cologic agents have been administered to learning disabled 
children. Although the use of these drugs has been long 
and diversified, an accurate assessment of the advantages 
and disadvantages of using chemotherapy with children having 
learning disabilities poses considerable problems. 
Despite the lack of knowledge concerning the specific 
effects of psychoactive medications in learning disabled 
children, they are frequently given these medications as 
if the behavioral consequences of such drugs were already 
known. 
Since the effects of many psychoactive medications 
are not really predictable, shouldn't one question why so 
many children are placed on these drugs without some effort 
to measure their effectiveness? 
Even though most of the research concerned with 
psychoactive drugs and learning disability children seems 




with the administration of certain drugs, these results 
certainly are not universal. Some studies have even re­
vealed an actual decrease in the learning abilities of chil ­
dren receiving stimulants. l , 2 
Purpose of the Paper 
It was, therefore, the purpose of this paper to 
examine the positive and negative aspects of using psycho­
active drugs with school-aged learning disabled children 
and to ascertain whether or not the positive results are 
sufficiently substantial to warrant the use of these 
behavior-modifying drugs. 
The results of this paper were obtained from pre­
existing research done in the field of psychoactive drug 
use with learning disabled children and also by means of 
an independent questionnaire sent by the author to all 
the pediatricians practicing in the ?1ilwaukee area and 
surrounding suburbs, as they were listed in the Milwaukee 
Telephone Directory. The questionnaire was an attempt to 
specifically evaluate the use of psychoactive drugs with 
learning disabled children in the author's own milieu. 
IH. Lobb, "Trace G.S.R. Conditioning with Benzedrine 
in lvIentally Defective and Normal Adults," American Journal 
of Mental Deficiency 73 (1968):239-246. 
2A • Bell and J. P. Zubek, "Effects of Deanol on the 
Intellectual Performance of ~Iental Defectives,1I Canadian 




Because this research derived its basis from be­
havioral disorders as they are associated with brain dysfunc­
tions, L~arning Disabilities was defined in this paper 
according to the definition put forth by Johnson and Myklebustl 
which implies a psychoneurological dysfunction: 
••• We refer to children as having a psychoneurological, 
learning disability, meaning that behavior has been dis­
turbed as a result of a dysfunction of the brain and that 
the proplem is one of altered processes, not of a general­
ized incapacity to learn. 
Psychoactive drugs liere defined as those drugs which 
effect a behavioral change in the learning disability child. 
Amphetamine was defined as a drug acting as a 
stimulant on the central nervous system. 
Hyperkinesis was defined as constant and excessive 
~ovement and motor activity. 
Hyperactivity was used to explain excessive activity. 
This term was used to pertain to the child who seems to have 
a surplus of energy and who is unable to control movements 
for even a short length of time. 
Psychogenic hyperactivity was defined as over-
activity which arises from an unstructured environment rather 
than any organic dysfunction. 
Organic hyPeractivity was defined as overactivity 
which arises from an organic dysfunction which the child 
is unable to control himself. 
IDoris Johnson and Helmer Myklebust, ,!-earning Dis­
abilities: Educational Principles and Practices (New York: 
Grune and Stratton, 1967), p.~ 8. 
4 
Choreoathetosic movement refers to the slight, 
irregular, jerking movements of the body caused by in­
vo1untary muscular contractions. 
The specific drugs presently being used to treat 
learning dis.ability children were categorized according to 


























There is little available info~ation on the advan­
tages and disadvantages of using psychoactive medication 
with learning disability children. 
The purpose of this paper was twofold: first, to 
peruse the available literature on psychoactive drugs and 
their use with the learning disability child and to obtain 
pertinent local information about psychoactive drugs and 
their use by pediatricians in the Milwaukee area and sur­
rounding suburbs; secondly, to evaluate whether or not the 
research results warrant the use of psychoactive drugs with 
learning disabled children. 
Definitions of Learning Disabilities, Psychoactive 
drugs, Amphetamine, hyperkinesis, hyperactivity, psychogenic 
hyperactivity, organic hyperactivity, and choreoathetosic 
were given, along with a list of the drugs currently being 
administered to L.D. children. 
In Chapter II, the reader will find a composite of 
the research regarding learning disabilities and the use of 
psychoactive drugs. 
CHAPTER II 
A REVIIDi OF THE LITERATURE 
An Overview of the Beginnings of Drug Use with 
Behaviorally Disturbed Children 
The history of treatment of behavior disorders in 
children with medications is not new. In 1937, Bradleyl 
wrote the -first of a series of .articles stating that the 
amphetamines had a beneficial effect on both learning and 
hyperkinesis. Bradley's surprising article indicated that 
amphetamines were of more value than small classes and 
psychotherapy. 
Bradley's report was followed by numerous other 
reports. With the exception of one,2 those first studies 
were uncontrolled. Since then, however, well designed 
double-blind studies on the effects of drugs have been 
1Charles Bradley, "The Behavior of Children Receiving 
Benzedrine,n American Journal of PSlchiatry 94 (September 
1937):577-585. 
2Matthew ~lolitch and August K. Eccles, "The Effect 
of Benzedrine Sulfate on the Intelligence Scores of Children," 




reported by Conners,l Eisenberg,2 and others. 3,4,5 Their 
research included the effects of drugs on hyperkinesis and 
on learning disorders. 
I~ 1958, Zimmerman and Burgemeister6 first used 
methylphenidate (Ritalin) on children with behavior disorders. 
Methylphenidate was found to act as a brain stabilizer, thus 
decreasing hyperkinesis and improving learning. The studie~ 
lKeith C. Conners, Leon Eisenberg, and Auner Darcai, 
"Effect of Dextroamphetamine on Children: Studies on Sub­
jects ,,,ith Learning Disabilities and School Behavior Problems," 
Archives General Psychiatry 17 (October 1967):478-485. 
2Leon Eisenberg et al., "A Psychopharmacologic Experi­
ment in a Training School for Delinquent Boys: Methods, 
Problems, Findings," American Journal of Orthopsychiatry 
33 (April 1963}:431-447­
3Keith C. Conners and Gerald H. Rothschild, "Drugs 
and Learning in Children," in Learning Disorders, ed. 
Jerome Hellmuth (Washington: Special Child Publications, 1968), 
pp. 1.91-223­
. 4Keith C. Conners, Leon Eisenberg, and Lawrence 
Sh~rpe, ItEffects of ~Iethylphenidate (Ritalin) on Paired­
Associate Learning and Porteus Maze Performance in Emotion­
ally Disturbed Children," Journal of Consultant PsycholoGY: 
28 (February 1964):14-22. . 
5Keith C. Conners, et al., "Dextroamphetamine Sulfate 
in Children with Learning Disorders: Effects on Perception, 
Learning and Achievement," Archives General Psychiatrl 21 
(August 1969):182-190. 
6F• T. Zimmerman and B. B. Burgemeister, "Action 
of ~lethylphenidylacetate ('Ritalin) and Reserpine in 
Behavior Disorders in Children and Adults," American Journal 




by Conners and Comly further attested to the effective­
ness of the amphetamines and methylph.enidate. 
The era of psychoactive drugs erupted in the 1950's. 
Besides the amphetamines and methylphenidate, tranquilizers, 
antihistamines, and the Phenothiazines or anticonvulsants 
emerged. This group of drugs all have some double-blind, 
controlled studies that uphold their claims of value, but 
none compare to the extensive bibliography of methylpheni­
date and the amphetamines. 
The accumulation of the literature on psychopharma­
cologie drugs evoked cries from parents whose children were 
experiencing problems in school. Those parents were de­
mariding better educational programs. Thus, an abundance 
of research studies was initiated to investigate learning 
disabilities and deviant behavior in children. This was 
followed by an outcry for effective drug treatment. 
The urgency for effective drug control created an 
environment which produced many studies which lacked long­
tenm scientific investigation and validation. 
lKeith C. Conners, "Recent Drug Studies with Hyper­
kinetic Cllildren, ff Journal of Learning Disabilities 4 
(November 1971):14. 
2Herbert H. Comly, "Cerebral Stim.ulants for Children 
l~ith Learning Disorders, t1 Journal of Learning Disabilities 
4 (November 1971):484-490• 




The Problem of Terminol~gx 
This era was also besieged by other problems, one 
of which was terminology. The question of what type of 
child benefits most from the use of psychoactive medica­
tion was unclear and still remains a dilemma today. 
A great deal of the problem in methodology is due 
to the lack of an operational definition of minimal brain 
dysfunction, learning problems, and deviant or hyperactive 
behavior. This produces confusion in th~ choice of drug and 
the evaluation of its effectiveness. 
1To illustrate this problem, Stewart in 1970 compared 
the characteristics of thirty-seven hyperactive children 
aged five to eleven, with a group of first grade children 
who matched the patient group except for a younger average 
age. The two groups were found to be "significantly diffe:r­
ent ff on a number of characteristics described by mothers of 
the two groups. 
Eighty-four percent of the hyperactive children were 
described as not finishing projects while none of the con­
troIs were so described as displaying this characteristic. 
1M• Stewart, "Hyperactive Children," Scientific 
American 222 (1970):94-98. 
" ,. ~~: 
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lFish takes an entirely different view. She be­
lieves that hyperactivity is a nnon-speci.fic symptom" that 
may be present in a child with a mild behavior problem or 
in a child with severe brain damage or schizophrenia or may 
be associated with disorders of inte~ediate severity. 
Fish states, 
The type of therapy to which the hyperactive child 
responds will depend upon his age, the maturity and 
intactness of his central nervous system, a¥d the 
severity and nature of his psychopathology. 
It has been est~ated that 3 percent of elementary 
school children demonstrate enough traits (mild and severe) 
to be classified as "hyperkinetic. 1t Such a percentage 
imp1ies that~ in a group of thirty to thirty-five pupils, 
one might expect to find one such child. More males than 
females are usually affected and no geographical area, 
country or social class is immune to hyperkinesis. 3 
IBarbara Fish, "Problems of Diagnosis and the Defini­
tion of Comparable Groups: A Neglected Issue in Drug Re­
search with Children," American Journal of Psychiatry 125 
(1969):900-908. 
2Ibid., p. 902. 
30ffice of Child Development (Department of Health, 
Education and l1elfare), "Report of the Conference on the 
Use of Stimulant Drugs in the Treatment of Behaviorally 
Disturbed Young School Children, It in JOLlrnal of Learning 
Disabilities 4 (November 1971):5Z3-530. 
11 
One of the characteristics of the learning disabled 
child is hyperactivity. However, with such discrepancies 
in the definitions of hyperactivity and methodology one 
must ask -the questions, nOn what basis should medication 
be recommended?" and IfHow does one knoli when to begin to 
consider medication as a possibility?" 
In a study done by Knobell in 1962, he suggested 
that there are two major types of overactivity: organic 
and psychogenic. Organic hyperactivity is dete~ined by 
an organic dysfunction, while psychogenic hyperactivity 
arises from a loosely structured environment. 
The organic child cannot control his behavior; the 
psychogenic child can physically control his behavior but 
has been preconditioned not to do so. Knobel states: 
The organic is erractic, without direction or objec­
tive. His behavior is almost ceaseless and without change 
in home, school, or any other social situation, and is 
generally accompanied by some slight choreoathetosic 
movement. (Choreoathetosic refers to slight, irregular, 
jerking movements caused by involuntary muscular con­
tractions) The aggressivity and impulsivity are without 
goal and apparently senseless. The child's inability . 
to postpone gratification is endless and urgent whether 
he is at home, in school, or wherever he may be. 
The psychogenic, on the other hand, • •• shows some 
direction and intentionality in his aggressivity and 
impulsivity-. In this child it is possible to obtain cer­
tain structure and coordination in various aspects 
ll-l. Knobel, UPsychopharmacology for the Hyperkinetic 






of his behavior which certainly might be different 
according to where the child finds himself or with whom 
he relates himself.! 
Therefore, the nonorganic hyperactive child should 
respond to firmness and structure on the part of parents and 
teachers along with behavior modification techniques. The 
organic child may want to respond, but is not able to. 
Knobel also feels that children who can benefit from medi­
cation do ~ot show much overt acting-out behavior, but do 
show a profound inability to stay on task or to maintain 
average attention span. On the other hand, the nonorganic 
child can accomplish task maintenance and concentration if 
he is sufficiently motivated. 
Definitive validation of either form of overactivity 
2is un1ikely, but an article by ~Iurray suggests some charac­
teristics commonly demonstrated by children which may help 
parents and educators to decide whether organic or environ ­
mental causation exists: 
Or~anic Characteristics 
1. Does the child show very little goal-directed 
behavior? (He starts many projects but finishes few.) 
1 Ibid., p. 31. 
2Joseph N. Murray, "Is There a Role for the Teacher 
in the Use of ~ledicati.on for Hyperkinetics?" Journal of 
Learnin~ Disabilities 9 (January 1976):32. 
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2. Do high motoric levels exist at home, school, 
everywhere? 
3. Does the child demonstrate an inability to inhibit 
his impulsiveness? 
4. Does he perform poorly on tests of visual and 
auditory memory? 
5. Are the child's comments often unrelated to what 
is presently being discussed? 
6. Does the child experience difficulty in logical 
reasoning or have problems following directions? 
7. Is the child easily distracted and does he exhibit 
explosive and unpredictable behavior? 
Psychogenic Characteristics 
1. Does the child show a lack-of-goal-directed 
behavior, but if he becomes involved with something that 
interests him he has the physiological capability to pursue 
and to complete it? 
2. Does this child demonstrate a high level of 
motor behavior, but individual counseling, behavior modifica­
tion, and other techniques can be successful? (Note: The 
psychogenic child will not exhibit high-motoric behavior in 
all settings as does the organic child.) 
3- Does the child have the ability to inhibit his 
behavior; does he have the ability to be reflective and plan? 
14
 
4. Does the child perform well on visual and 
auditory retention tasks. (Note: This implies that 
developmental and intellectual factors are constant.) 
5. Does the child manifest few, if any, "off the 
track" or dysrhytlunic responses? 
6. Deficient reasonIng processes and ability to 
follow directions are seldom seen as hard signs. These 
capabilities exist if the child decides to use them. 
7. This child's behavior is more calculated and 
premeditated than the organic child's. 
Having established some criteria for separating 
organic hyperactivity from psychogenic hyperactivity, 
what other measures should be utilized before a drug therapy 
pi'0&4- <.4~~. is recommended? First, educators should measure 
the specific behaviors which are handicapping the child 
academically and socially. These data should be collected 
in a systematic way. This will assure an objective descrip­
tion of the behavior" and allow the observers 8.n opportunity 
to remeasure the deviant behavior after the intrOduction 
of medication. 
The teacher is in the best position to record 
anecdotal records and the school psychologist can collect 
baseline data if the teacher is not familiar with these 
procedur-·es. 
15 
Observations should be taken often and at different 
times of the day throughout the week.
 
After collecting the data, the second step is to
 
meet with the child's parents. The teacher and psychologist 
relate to the parents their findings along with the techniques 
that have been used to modify their child's behavior. If 
none of the treatments have met with success, the teacher 
and psychologist may suggest that the parents see their 
doctor with regard to some form of drug therapy for their 
hyperactive child. 
If the parents agree, the third step involves for­
warding all pertinent records to the child's physician. 
Along with these records the physician should make his own 
examination and diagnosis. This would include the follow­
ing: 
1. A complete medical history 
2. A physical examination which would include a 
routine neurologic examination and 
3. A special neurologic evaluation for minor 
neurologic dysfunction. 
Finally, if the physician's evaluation coincides 
with the other professionals I findings, with permission of 





lVhen it is determined that medication is warranted 
in the case of a learning disabled hyperactive child, many 
questions should be investigated: (1) 'Vhat drugs will be 
used? (2) How do these drugs work on the central nervous 
system? (3) How successful are the drugs? (4) What side­
effects might one expect to see? (5) 'ihat improvement 
should be seen in the behavior, cognition and motor behavior 
of the child? 
Numerous drugs have been used in the treatment of 
behavioral disorders in children but Eisenberg, Laufer and 
1Denhoff, Millichap and Fowler and Werry to name a few have 
found the amphetamines (Dexedrine) and methylphenidate 
(Ritalin) to be the most effective drugs in treating 
hyperactivity. The drug Pemoline (Cylert) also was cited 
2 as significant in treating this symptom. 
lSee L. Eisenberg, "The !-lanagement of the Hyper­
kinetic Child, n Developmental Medical Child Neurologist 8 
(1966):593-598; M. Laufer and E. Denhoff, "Hyperkinetic Be­
havior Syndrome in Children," Journal of Pediatrics· 50 (1957): 
463-474; J. lvIil1ichap and G. FO'Y'ler, nTreatment of Minimal 
'Brain Dysfunction Syndrome, n Pediatric Clinics of' North 
America 14 (1967): 767-777; J. '-[erry" "Developmental Hyper­
activity," Pediatric Clinics of North America 15 (1968): 
581-599. 
2John G. Page, et al., "Pemoline (Cylert) in :the 
Treatment of Childhood Hyperkinesis," Journal of Learning 




The decision to administer one or the other of 
these drugs depends largely on the physiciants experience
 
with the drug and hOli the cllild responds to the drug.
 
The site and mechanism of action of the stimUlant
 
drugs in hyperkinesis was not definitely established at
 
the time of this study. However, several theories were
 
available for review: the studies by Eisenberg, Bradley,
 
Conners and Rothschildl have found that amphetamines,
 
which normally act as stimulants, producing increased
 
activity, have been found to paradoxically reduce activity
 




There is also some evidence to suggest that the 
general state of the organism, that is the level of activity 
or metabolism in the nervous system, prior to the adminis­
tration of the stimulant drug becomes a determining factor 
2in the action of such drugs. This suggests that tIle 
l See Eisenberg, "The Management of the Hyperkinetic 
Child," pp. 593-598; Charles Bradley, flBenzedrine and 
Dexedrine in the Treatment of Children's Behavior Disorders,tt 
Pediatrics 5 (1950):24-37; Conners and Rothschild, "Drugs 
and Learning in Children," pp. 191-223. 
2volbehr \'1. Ladisich and N. Matussek, "Paradoxical 
Effect of Amphetamine on Hyperactive States in Correlation 
with Catecholamine lvI~tabolism in Brain, n in Amphetamine 
and Related Compounds, eds. E. Costa and S. Garattini (New 
York: Raven Press, 1970), pp. 318-325. 
18
 
so-called paradoxical calming or depressant effects of 
amphetamine on both normal adults and hyperactive children 
can be accounted for by the theory that amphetamines will 
increase arousal when the initial level of arousal is 
low but will decrease arousal when the initial level of 
arousal is high. 
Therefore, children who are not engaged in hyper­
active behavior should not be given medication as this 
will promote activity rather than inhibit it. 
lKnobel perceives the problem as one of the lack 
of cortical maturation. The hyperactive child expresses 
himself with typically subcortical behavior characterized 
by lack of control, poor reality-testing capacity and 
handicapped motor-abilities. He believes that pharmacologi­
cally, methylphenidate probably acts like amphetamine as 
a cerebral stimulant affecting the cerebral cortex, allowing 
for a true integration of behavior. 
lH. Knobel, "Psychopharmacology for the Hyper­




1Conners and Rothschi1d in 1968 stated that the 
drug action in the hyperkinetic child is not a pha~a-
cological.ly true paradoxical effect, but rattler a direct 
stimulating effect of the amphetamines which causes an 
increase in general alertness and excitation along with an 
increase in the ability to focus attention. 
Ho\i' Successfut is the Drug? 
In January, 1971, the Office of Child Development 
and the Office of the Assistant Secretary for Health and 
Scientific Affairs, conducted a conference on the "Use of 
Stimulant Drugs" with behaviorally disturbed children. 2 
This conference concluded that medicine does not 
"curett the hyperactive condition, but a child may become 
more susceptible to educational and counseling efforts. 
It was suggested that drugs administered over a short 
term and at a critical age, could provide the assistance 
needed to promote further development in the child. 
The conference further concluded that stimulant 
medications are beneficial in only about one-third to two-
thirds of the cases in which trials of the drugs are 
warranted. 
lConners and Rothschild, "Drugs and Learning in 
Children," pp. 191-223. 
20ffice of Child Development, "Report of Conference 
on the Use of Stimulant Drugs," p. 523. 
20
 
How a child will respond to stimulant medication 
cannot be prejudged. 'Vhen psychoactive drugs are given 
~n adequate doses and a favorab1e response occurs after a 
short period of tilne, it can be concluded that the drug is 
effective. Conversely, if after an adequate period of time 
no noticeable improvement is evident, the drug can be ter­
minated or the dosage regulated. 
If stimulants improve the attention of the hyper­
kinetic child, he is likely to spend more time in con­
centrated tasks and 1ess time demonstrating inappropriate 
behavior. 
The Side-Effects of Psychoactive Medication 
Along with the beneficial action of amphetamine and 
methylphenidate on hyperkinesis some secondary negative 
effects must be considered. These negative effects fre­
quently receive only passing attention and they may with 
prolonged medication seriously affect the physical well 
being of the learning disabled child. 
In general the only toxic reactions noted by physicians 
associated with the amphetamines and methylphenidate are: 
21
 
insomnia, loss of appetite, gastrointestinal disturbance, 
irritability, crying and headache. 1 
Increase in anxiety, temper tantrums and an exaggera­
tion of the pre-existing hyperactivity have also been re­
2ported. 
Most authors agree that these toxic effects are 
usually Dlild and cessation of therapy or dosage adjustments 
rectify the problem. 3 
Bradley,4 in his 1950 follow-up study of 340 
patients reported no major problems with toxicity. He 
also found no deleterious changes in blood pressure, pulse, 
liver function, kidney function or blood-forming organs. 
Epstein and others5 reported similar findings but 
also discovered that children who seemed to have damage of 
1Epstein et a1., "Correlation of Dextroamphetamine 
Excretion and Drug Response in Hyperkinetic Children," Journal 
of Nervous and Mental Disease, 146 (February 1968):136-146. 
2501 Levy, "The Hyperkinetic Child," General Practioner: 
37 (June 1968):112-116. 
3Andersen, et a1., "The Effect of D-amphetamine on 
Obese Children, n Danish };Iedical Bulletin 1 (August 1954) :118~ 
123. 
4Bradley, "Benzedrine and Dexedrine in the Treatment 
of Children's Behavior Disorders," pp. 24-37. 
5Epstein, et a1., "Correlation of Dextroamphetamine 




the nervous system excreted amphetamine in larger amounts 
and more rapidly than did those whose hyperactivity could 
not be attributed to central nervous system impairment. 
lIn 1967, Millichap and Fowler analyzed the drugs 
used for hyperactivity according to effectiveness and 
toxicity. They found methylphenidate to be the drug of 
choice and amphetamine sulfate the second most successful 
drug. 
The side-effect of anorexia was examined in a study 
· 2b y L asagna and Eps t e1n. These authors observed a 
diminished appetite and a loss of weight in hyperkinetic 
children placed on amphetamine. 
Knights and Hinton3 observed a significantly greater 
incidence of appetite loss in a group of hyperkinetic 
children given methylphenidate over a group of similar chil ­
dren treated with placebo. 
Another secondary effect of dextro-amphetamine and 
methylphenidate which has caused some concern involves the 
1J. !4illichap and G. Fowler, II Treatment of Minimal 
Brain Dysfunction Syndrome," pp. 767-777. 
2L• Lasagna and L. Epstein, "The Use of Amphetamines 
in the Treatment of Hyperkinetic Children," in Amphetamines 
and Related Compounds, eds. E. Costa and S. Garattini (New 
York: Raven Press, 1970), pp. 406-412. 
. 3R• Knights and G. Hinton, "The Effects of l<lethyl­
phenidate (Ritalin) on the Motor Skills and Behavior of 
Children lvith Learning Problems,11 Journal of Nervous and 
Mental Disorders 148 (October 1969):643-653. 
23
 
effect of stimulant drugs on the cardiovascular system. 
Some studies have suggested that methylphenidate does not 
promote hypertensive effectsl and does not produce an in­
2 crease in a child's heart rate. 
A more recen-c study, however, using methylphenida·te, 
reported an increase in the basal level of heart rate during 
rest. 3 Dextro-amphetamine, according to the Dexedrine 
Reference Manuel~ has little or no significant effect on 
the cardiovascular system. 
Needless to say, the effects of psychoactive medica­
tion on the cardiovascular system still warrant consider­
able research. 
In 1973 Safer and AlIenS reported that the long­
te~ use of dextro-amphetamine in hyperactive children 
IR. Maxwell, et al., "Studies Concerning the Cardio­
vascular Actions of the Central Nervous Stimulant Methyl­
phenidate,n Journal of Pharmacolo ical Ex erimental Thera­
peutics 123 195 :22-2. 
2C • Carter and M. Maley, "Parenteral Use of Methyl­
phenidate {Ritalin),n Diseases of Nervous System 18 (1957): 
146-148. 
3Cohen, et al., liThe Effect of Methylphenidate on 
Attentive Behavior and Autonomic Activity in Hyperactive Chil­
dren, ff Psychopharmac.ologia 22 (1971): 282-294­
4Dexedrine Reference Manuel (19S9), S.V. "Dextro­
amplletamine . " 
SDaniel J. Safer and Richard P. Allen, "Factors In­
fluencing the Suppressant Effects of Two Stimulant Drugs on 




caused significant gro\vth suppression in height and weight, 
and that the long-term use of methylphenidate, when given 
in doses over 20 mg., caused growth retardation but to a 
lesser degree than dextroamphetamine. 
Safer and AlIenI found in a follow-up study done in 
1975, that when the stimulant medications dextroamphetamine 
and methylphenidate were discontinued over the summer 
months, hyperactive children displayed a weight gain 
significantly greater than that of comparable hyperactive 
children whose medication was continued throughout the 
summer. In fact, discontinuance of the medication resulted 
in a growth rebound for this period which was 15 to 68 
percent above the age-expected increment. 
With long-term abuse of the amphetamines, psychotic-
like episodes have been found, and one study reported 
psychosis in a child receiving minimal amounts (10 to 15 
mgs. per day) of dextroamphetamine. The symptom disappeared 
after discontinuance of the drug and reappeared when it 
was started, but disappeared gradually even though dextro­
amphetamine was continued, and had not reappeared after 
2 
one year of therapy. 
, 
~Daniel J. Safer, Richard P. Allen and Evelyn Barr, 
ttGrolvth Rebo!..lnd After Termination of Stimulant Drugs, It 
Pediatrics 86 (January 1975):113-116. 
2Leon Oettinger, "Learning Disorders, Hyperkinesis, 
and the Use of Dr:.lgs in Children," Rehabilitation Litera­
ture 32 (June 1971):163. 
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The potential addictive properties of psychoactive 
drugs such as dextro~amphetamine and methylphenidate are 
somewhat unclear, although recent evidence indicates that the 
use of such drugs in the treatment of hyperkinetic children 
has resulted in no clear support for addiction. l 
Evidence for the addictive properties of psychoactive 
drugs seems to depend upon two factors--dosage and age. The 
risk of the misuse of stimulant drugs becomes prevalent in 
adolescents, who experiment with the effects of excessive 
dosages to create excitement or to combat fatigue. This is 
one of the chief reasons why stimulant drugs are not often 
prescribed for children after eleven or twelve years of age. 
The use of stimulant drugs in the treatment of hyper­
kinetic children does not seem to produce a ffpep-up" or 
flh·J..gh • ,,2 The dosage is not given in sufficient amounts 
to supply the drug abuse. The daily dosage of dextro­
amphetamine is 15 to 20 mgs. and in the case of methylpheni­
date, 40 to 60 mgs. per day is normal. The drug addict may 
use as much as five grams of methylphenidate in a single day.3 
ISherwood O. Cole, "Hyperkinetic Children," American 
Journal of Orthopslchiatrl 45 (January 1975):34. 
20ffice of Child Development. "Report of Conference 
on the Use of Stimulant Drugs," p. 527. 
3D• Smith, "Speed Freaks Versus Acid Heads," Clinical 
Pediatrics 2 (1969):185-192. 
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Finally, there is also the psychological stigma the 
public often imposes on the child taking psychoactive- medica­
tion. lIe is often called a "drug-taker" and, in fact, 
treated as an addict. 
How Psychoactive Medication Affects Behavior 
and Learning 
If medication has been successful, one should see 
some noticeable improvement in the academic, motor and 
social behaviors of the learning disabled child. 
Werry and Spraguel in a study using dextro-ampheta­
mine, clearly demonstrated that after a four-week period, 
the parents of the children placed on medication noted a 
considerable decrease in excessive activity at home, in con­
trast to the children treated with placebo. 
Motor behavior has been studied by many diverse 
methods in the laboratory. '~ile there is some failure to 
replicate and there are some inconsistencies in the data, 
they generally support the claims that in hyperactive children 
directed or controlled motor activity is increased by psycho­
active medication. However, various stimulants have diverse 
effects on motor functions. 
In a recent comparison of Pemoline (Cylert) and dextro­
amphetamine, it was reported that Cylert 
1J. S. 'verry and R. L. Sprague, "Hyperactivity," in 
Symptoms of PSlchopathologr, ed. C. Costello (New York: 
Wiley Press, 1970). 
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was significantly superior to Dexedrine in improving fine 
motor control in a set of scores derived from the Lincoln­
1
Oseretsky Scal~. 
Studies of free-field activity, using actometer 
measurements and time-stop photography, showed that stimu­
lant drugs actually increase the total amount of activity.2 
These authors discovered that it is the quality of activity 
rather than the amount of energy expanded that is changed 
by drugs. 
Wade3 reported in 1976 that in a study with twelve 
normal and twelve hyperactive children in which some of 
the hyperactive students were placed on methylphenidate and 
some on placebo, the medicated hyperactive children performed 
more like their nonmal peers than those who received a 
placebo. 
The studies by Bradley and others demonstrated that 
Dexedrine and Benzedrine affected general intelligence 
measures. 
1Connors, "Recent Drug Studies with Hyperkinetic 
Children," p. 479. 
2J • G. Millichap and E. E. Boldrey, "Studies in Hyper­
kinetic Behavior," Neurolou 17 (1967):467-471. 
3}'Iichael G. Wade, "Effects of loiethylphenidate on 
Motor Sl<ill Acquisition of Hyperactive Children, n Journal 
of Learning Disabilities 9 (August/September 1976):443-447. 
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1A report by Page and others using hyperactive 
children medicated with Pemoline and placebo note~ a signi­
ficant increase in the WISe Full Scale and its Performance 
I.Q. component; lvrat reading and arithmetic grades; and 
Factor II of the Lincoln-Oseretsky Motor Performance Test. 
They also found improvement in the Pemoline group over 
placebo on the Goodenough-Harris Draw-A-Person. The improve­
nent on the 'vISe Verbal I. Q. was significant at the 10 per­
cent level. However, the Porteus Maze test, found by some 
to be sensitive to stimulant drugs, did not discriminate 
between the Pemoline treated subjects and those on placebo. 
Knights and Hinton2 found that Ritalin significantly 
increased WISe Performance I.Q. in hyperactive children. 
This was also noted by Epstein, et al. 3 
Conversely, Finnerty, et a1" Conners and Rothschild 
and Conners et aI, failed to find improvement of WIse I.Q. 
4scores. 
lJohn G. Page, et al., "Pemoline (Cylert) in the Treat­
ment of Childhood Iiyperkinesis," Journal of Learning Dis­
abilities 7 (October 1974):498-503. 
2Knights and Hinton, "The Effects of t-fethylphenidate 
(Ritalin) on the Motor Skills and Behavior of Children with 
Learning Problems," pp. 643-653. 
3Epstein, "Correlation of Dextro-amphetamine Excretion 
and Drug Response in Hyperkinetic Children,tt pp. 136-146. 
4See D. Finnerty, et al., "The Use of D-Amphetamine 
with Hyperkinetic Chilclren, n Psycho-pharmacologia 21 (1971): 
302-308; Conners and Ro1~!lschild, "Drugs and Learning in Chil­
dren," pp. 191-223; Conners, et al., If Dextroamphetamine Sul­
fate in Children with Learning Disorders," pp. 182-190. 
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Sprague, Barnes and werryl showed in their research 
that methylphenidate increases the number of correct responses 
when compared to children medicated with placebo and thiorida­
2zine (Mellaril)_ Conners, Eisenberg and Sharpe also dis­
covered that rote paired-associate learning is significantly 
enhanced by the stim~lants. 
In a more recent study, however, Rie, et a13 found 
that while Ritalin affects behavior it did not enhance 
learning and may in fact mask academic problems. 
It should also be noted that in studies comparing 
stimulants with the Phenothiazines or tranquilizers, the 
latter ShOlv impairment of learning and cognitive functions 
in hyperactive children. 4 This may also be said in regard 
to the use of Dilantin and the tricyclic antidepressant com­
pounds with hyperactive L.D. children. 5 
1 R. L. Sprague, K. R. Barnes and J. S. Werry, 
"Methylphenidate and Thioridazine," American Journal of 
Orthopsychiatry 40 (1970):615-628. 
2Conners, Eisenberg, and Sharpe, lIEffects of 
Methylphenidate (Ritalin) on Paired-Associate Learning," p. 20. 
3Herbert E. Rie, et al., "Effects of Ritalin on Under­
achieving Children," American Journal of Orthopsychiatry 
46 (April 1976):313-322. 
4Conners, "Recent Drug Studies \'1ith Hyperkinetic 





How does one explain the great diversity of findings 
in the use of drugs with hyperactive learning disabled 
children? One explanation may lie in the great heterogeneity 
of the subjects. In other words, the effects of psycho­
active medication do not pertain to all "hyperactive" 
children. This problem of diagnostic heterogeneity is an 
important issue in drug research. 
Secondly, the subjects differ on several parameters 
of brain functions. 
Summary and Conclusions 
Since 1937 when Bradley discovered the paradoxical 
effects of the amphetamines on hyperactive learning dis­
abled children there have been many studies. Some of these 
supported Bradley's findings others did not. Many problems 
are associated with the use of drugs with children. 
Terminology is a major problem. Defining what type 
of child benefits most from psychoactive medication remains 
to be determined, although the organically-based hyperactive 
child has shown the most progress when placed on drugs. 
It was found that when a child is suspected of 
needing medication to control his hyperactivity a thorough 
assessment by the teacher, parents and physician is essential. 
It was not determined at the time of this study how the 
drugs actually affect the brain. 
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Methylphenidate and the amphetamines were found to 
be the most effective drugs in treating the hyperactive L.D. 
child. 
Psychoactive medication was found to be of value in 
only one-third to two-thirds of the cases where they were 
administered. 
Side-effects include insomnia, loss of appetite, 
cardiovascular symptoms and gro\vth retardation to name a 
few. 
The use of psychoactive medication in the treatment 
of hyperactive children has resulted in no clear support 
for addiction. However, it was found that age and dosage 
play an important role. 
The reported research has also supported claims that 
directed or controlled motor activity is increased by 
medication. 
It is still debatable whether or not drugs affect 
I.Q.	 scores. 
Therefore, the results of this study l~d the author 
to arrive at the following conclusions: 
First, a drug program should ensue only after other 
treatment has been initiated, given a fair trial period and 
assessed as unsuccessful; and secondly, a thorough medical, 
social and academic evaluation must be undertaken. 
The positive effects of medication would include 




The properly medicated child would present less of 
a discipline problem both in social and academic settings. 
It was found that the hyperactive L.D. child would be less 
socially isolated from his peers and that medication would 
allow him to be more predisposed to a learning atmosphere. 
Although the psychoactive drugs do have a place in 
the treatment of hyperactive learning disabled children, 
the author concluded that there are many more negative than 
positive aspects associated with their use that must be con­
sidered and researched more thoroughly. 
Those problems would include the high incidence of 
placebo effect, growth retardation, loss of appetite, a 
lack of studies to determine long-term effects of the drugs, 
the discrepancies in the cardiovascular research, the in­
ability to pre-judge how a child will react to medication and 
the fact that psychoactive drugs are successful in only 
one-Lhird to two-thirds of the cases where they were used. 
Another ~portant aspect to be considered was the 
fact that drugs offer only a temporary solution. The studies 
showed that once the medication is stopped, the symptoms 
reapp~ar. 
Therefore, the author felt that the hope for the 
hyperactive L.D. child lies not in psychoactive drugs but 
in comprehensive programs which involve parents and teachers. 
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Better trained and informed teachers mean less boredom and 
disinterest in the classroom for the hyperactive L.D. child. 
This promotes an atmosphere of learning not chaos. Parents 
who are aided by remedial techniques, psychological advice 
and understanding teachers will contribute more to the 
self-confidence and self-image of the hyperactive L.D. 
child than any psychoactive medication. 
Finally, if it is determined that a psychoactive 
drug program is the only alternative that will allow the 
hyperactive L.D. child to function more "normally" in his 
environment, it should only be undertaken after a critical 
evaluation and with caution. 




The Ouestionnaire and Its Results 
Ot . 
The author sent out a questionnairel to all the 
pediatricians in the Milwaukee area and surrounding suburbs. 
The purpose of the questionnaire was to ascertain how local 
pediatricians felt about the use of psychoactive medication 
with learning disabled children. Sixty-eight questionnaires 
were sent out and fifty-one were returned, however, one of the 
questionnaires was returned not completed, containing only 
the comment that "there is no such thing as an L.D. child. 1I 
Th.e survey yielded the following results: the 
majority of the doctors (thirty-six' out of fifty) fell in 
the forty~to-fifty-year-oldage group. With the exception of 
four, all the doctors were male. Thirty-three of the doctors 
practiced in Milwaukee and of the doctors who replied, 
,,;' .. 
thirty-five out of fifty had been in practice for ten to 
fifteen years. Forty of the fifty doctors practiced out of 




private offices. All the pediatricians had school-aged 
learning disability children as patients. Forty-three 
replied that they had at least one and not more than twenty. 
Only one of the fifty doctors stated that he was not 
familiar with the criteria used in determing a learning dis­
ability. The criteria most frequently checked by the 
doctors in order included: (1) short attention span; (2) a 
history of hyperactivity; (3) distractibility with or with­
out aggressiveness; and (4) learning, speech or memory 
deficits. An abnormal E.E.G. reading was used' least often 
as an assessment technique. Several of the doctors commented 
on its unreliability. The only discrepancy between these 
criteria and those in the reported research was that 
"hyperactivity" was used most often to diagnose a problem. 
Only ten of the fifty doctors did not prescribe drugs 
for their L.D. patients. Some of the ten doctors who did 
not recolmnend drugs offered their reasons for this decision. 
One doctor stated, 
Hyperactivity is usually an extension of normal male 
child behavior. It is best treated by 'teachers, not 
doctors. One on one tutoring is the most effective 
prescription for the hyperactive child. 
Another doctor wrote: 
Today's world is tough on our kids. School under­
achievers need to be helped. There are many ways of 
helping. Quick and easy are of course medications. • • • 
A team approach is really necessary. The diagnosis of 
tlhyperactivity" is abused and overcalled. 
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Other questionnaires included these replies: 
I do not prescribe drugs. I refer these patients 
for complete evaluation to the medical psychologist, 
psychiatrist and specialty persons when appropriate. 
"Some pal"'ents," said one pediatrician, "want their 
kids on the drugs long after the p.roblem has disappeared. ft 
The drug prescribed most often was Ritalin or 
Methylphenidate followed by Pemoline and Dexedrine. The 
only discrepancy here was the fact that Pemoline rather 
than Dexedrine was rated as the second most prescribed 
drug. On many questionnaires many doctors commented that 
they were stopping the use of Dexedrine. 
Of the other drugs listed on the survey, Mel1aril, 
Benadryl, Diamox, Dilantin and ftlysolin.e were used by some 
doctors. \Yhen the pediatricians were asked what they felt 
the most significant advantages of using drugs with L.D. chil­
dren were the majority rated better attention span as the 
number one advantage follo\t/ed closely by less hyperactivity. 
These data correlated with the research statistics. 
The doctors also confirmed the research data when 
they found anorexia and retarded growth to be the most 
significant disadvantages of drug use. Ho'vever, some doctors 




The majority (forty-three) of the pediatricians 
reported drugs to be sOJnewhat successful. Twenty-seven 
doctors prescribed drugs on a day-to-day basis and all but 
two of the doctors who prescribe drugs stated that they 
should not be limited to academic settings. One doctor 
wrote: 
I recommend drugs in other than academic settings 
because teachers are not always as observant as they 
think they are and, in fact, have tunnel vision in 
observing patients. 
Most of the doctors (forty) saw the child placed on 
drugs once every two months after the initial trial period 
and the doctors often changed and adjusted the dosages of 
the drugs. 
The studies indicated once every two months is the 
usual amount of time for seeing a child on psychoactive 
medication. 
Conclusions 
From the results of this survey, the author concluded 
that the majority of the pediatricians in her milieu do pre­
scribe psychoactive medication for the L.D. child. It was 
also found that they do have some confidence in the use and 
success of these drugs although they feel more research is 




Questionnaire Sent To All Pediatricians 
1.	 What is your age? 
20-30 30-40 40-50 50-60 
6·0-70 70 and over 
2. lYhat	 is your sex? F M 
3.	 In what area of 'iisconsin do you practice? 
4.	 How many ¥ears have you been in practice as a 
pediatrician? 
1-5 5-10 10-15 15-20 20-25 
25 and over 
5.	 In what type of setting do you practice? 
Private Office __ Hospital 
Clinic ___ Other, please specify 
6.	 Do you have school-aged learning disability children 
as patients? 
Yes l-lo 
7.	 (Approximately) How Many? 
1-20 20-40 40-60 60 and over 
8.	 Are you familiar with assessment techniques used in 





9. '~ich of these criteria do you use in determining a 
learning disability? 
A history of hyperactivity	 Spastic Conditions 
Short attention span	 Abnormal BEG 
readingsDistractibility with or 
--- without aggressiveness Learning, speech 
or memoryPoor	 sleep ha~its difficulties 
Perseveration 
Convulsive dis­
Neurological abnormalities orders, headaches 
Poor coordination ___ Other, please 
specify 
Visual or hearing 
--- difficulties 
10.	 Do you prescribe drugs for your learning disability 
patients? 
Yes No 
11.	 On what research basis? 























13.	 If you do prescribe drugs for learning disability 
children, which drug do you prescribe most often 
and why? 
14- lVhat do you feel are the most significant advantage.s 
of using drugs with learning disability children? 
Less	 hyperactivity Loss of aggressiveness 
Better attention span	 Lessening of spastic 
conditions
Better coordination 
Other, please specifyBetter sleep habits 
15.	 \Vhat are the most significant disadvantages of using 
drugs with learning disability children? 
possible addiction	 Innate personality 
changes
Unforeseen side­
effects Other, please specify 
Allergic reactions 
Over	 Use 
16.	 How successful do you feel drugs are in the treatment 
of learning disabilities? 
No success ___	 Very successful 
Low success rate ___	 Outstanding resu~ts 
Somewhat successful 
17.	 Do you stipulate under what conditions the drug is to 
be administered or do you prescribe the drug on a 
day-to-day basis? 
Behavioral conditions Day-to-day basis 
42 
18.	 Should the use of drugs with learning disability 
children be limited to academic settings? Why? 
Yes	 No 
19.	 How often do you see the learning disability child 
after prescribing drugs for him or her? 
Once	 a week Once every two months 
Once	 a month Other, please specify 
20.	 Do you often have to adjust dosages and change 
drugs with learning disability children? 
Yes	 No 
21.	 Is more research in the area of drug therapy'with 
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